Jan Lüdemann

Title: Jan Lüdemann: Innovator in Pharmaceutical Solutions

Introduction

Jan Lüdemann is a notable inventor based in Uetersen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative solutions for digestive health. With a total of 2 patents, Lüdemann's work focuses on improving treatments for patients with exocrine pancreatic insufficiency.

Latest Patents

Lüdemann's latest patents include an orodispersible tablet containing burlulipase and a pharmaceutical composition produced from it. This invention is characterized by its ability to dissolve in water or other beverages, making it easier for patients to consume. The orodispersible tablets are particularly beneficial for treating digestive problems associated with exocrine pancreatic insufficiency, especially in cystic fibrosis and pediatric patients. Another significant patent involves an aqueous solution of burlulipase that includes calcium ions, which is also aimed at treating exocrine pancreatic insufficiency. This solution is designed for patients with cystic fibrosis and pediatric needs, showcasing Lüdemann's commitment to addressing critical health issues.

Career Highlights

Throughout his career, Jan Lüdemann has worked with reputable companies such as Nordmark Pharma GmbH and Nordmark Arzneimittel GmbH & Co. KG. His experience in these organizations has allowed him to develop and refine his innovative pharmaceutical solutions.

Collaborations

Lüdemann has collaborated with professionals like Richard Fuhrherr and Annika Müller-Lucks, contributing to the advancement of his projects and enhancing the impact of his inventions.

Conclusion

Jan Lüdemann's contributions to pharmaceutical innovations, particularly in the treatment of digestive disorders, highlight his role as a significant inventor in the field. His patents reflect a dedication to improving patient care and addressing complex health challenges.